《英國急性卒中管理共識指南》內(nèi)容預覽：

    This booklet has been published by CREST (the Clinical Resource Efficiency Support Team).CREST is a small committee of health care professionals established under the auspices of theCentral Medical Advisory Committee, to promote clinical efficiency in the health service inNorthern Ireland while ensuring that the highest possible standard of clinical practice ismaintained.

    CREST wishes to thank Dr Colin Fitzpatrick and the Working Group on New Drugs in theManagement of Acute Stroke for producing this guidance.Membership of the Working Group on New Drugs in the Management of Acute StrokeDr Colin Fitzpatrick, Eastern Health & Social Services Board (Chairman)Dr Margaret Chambers, General Practitioner, Willowbank Surgery, KeadyDr Paul Flanagan, Consultant Geriatrician, Antrim Area HospitalDr Ken Fullerton, Consultant Geriatrician, Belfast City Hospital -(Representative nominated by Chest, Heart and Stroke Association).

    Dr Mark Gibson, Consultant Neurologist, Royal Group of HospitalsDr Jim Kelly, Consultant Geriatrician, Erne HospitalDr Selbert Rainey, General Practitioner, Randalstown Health Centre,RandalstownDr Clive Russell, Consultant Physician, Tyrone County HospitalDr Michael Scott, Chief Pharmacist, Antrim Area HospitalDr Anne Marie Telford, Director of Public Health, SHSSBDr Michael Watts, Consultant Neurologist, Royal Group of HospitalsSecretariatDr Maura Briscoe, Medical Officer, Department of Health & Social ServicesMrs Isobel Scott, CREST SecretariatCopies of this booklet may be obtained from the CREST Secretariat, Room 517,Dundonald House, Upper Newtownards Road, BELFAST, BT4 3SF.

    Telephone: 028 9052 4391CONSENSUS GUIDANCE ON THE MANAGEMENT OF ACUTE STROKEIntroductionIn February 1998 the CREST Drugs Advisory Group set up a working group on new drugs in themanagement of acute stroke to provide professional advice on:(1) pharmacological approaches for the treatment of patients with cerebral ischaemia andhaemorrhage;(2) a regional approach to the introduction and use of new drugs which ensures equity ofdrug treatment for patients, with safe and cost effective prescribing;(3) the monitoring of the overall prescribing of such drugs in Northern Ireland.This guidance represents the consensus view of the group. It is interim guidance covering thedrugs currently available or likely to become available in the near future. It will be revised asnew drugs become available.The treatment recommendations in this consensus statement apply only to ischaemic events.Cerebral haemorrhage will need to be excluded before treatment is initiated. Whenever feasiblethis should be done as soon as possible with a CT scan......
  點擊下載完整版地址：《英國急性卒中管理共識指南》